ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that Joseph Gersuk , Executive Vice President and Chief Financial Officer, will not be able

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, will present at the 2011 RBC Capital Markets Healthcare Conference on Wednesday, March 2, 2011 , at 2:35

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO) announced today the launch of a new Morpheus ® SMART PICC bedside insertion kit and new 5 French Dual Lumen Peripherally Inserted Central Catheter (PICC) as part of the continued growth of its Morpheus SMART PICC line.

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO) today announced the receipt of a warning letter from the U.S. Food and Drug Administration ( FDA ) regarding certain aspects of the Company's marketing program for its NanoKnife® System.

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 29 th Annual J.P. Morgan Healthcare Conference at 2 p.m.

Net Sales of $53.4 Million , International Sales Rise 12% Net Income of $3.3 Million , or $0.13 EPS Gross Margin of 59.1% Operating Cash Flow of $9.9 Million Reiterates Fiscal Year 2011 Guidance Conference Call Today at 4:30 p.m. Eastern Time ALBANY, N.Y.

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will report its fiscal 2011 second quarter financial results on Tuesday, January 4,

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes and

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the Stephens Inc. Fall Investment Conference at 1:30 p.m.

ALBANY, N.Y., Nov 01, 2010 (BUSINESS WIRE) -- In the first graph, first sentence of release dated Oct. 25, 2010, the conference presentation time is incorrect. It should read: 2:45 p.m. ET (sted 4:30 p.m. ET). The corrected release reads: ANGIODYNAMICS TO PARTICIPATE AT THE 21ST ANNUAL OPPENHEIMER

ALBANY, N.Y., Oct 28, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that Kevin J. Gould, 56, was elected to its Board of Directors at the Company's

ALBANY, N.Y., Oct 25, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the 21 st Annual Oppenheimer Healthcare Conference at

<ul>
<li class="bwlistitemmargb">
<i><b>Net Sales of $51.5 Million</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Net Income of $1.9 Million, or $0.08 EPS</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Operating Cash Flow of $1.7 Million</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Updates Fiscal Year 2011 Guidance</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Conference Call Today at 4:30 p.m. Eastern Time</b></i>
</li>
</ul>

ALBANY, N.Y., Sep 28, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will report its fiscal 2011 first quarter financial results on

ALBANY, N.Y., Sep 14, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO) today announced the appointment of Scott Solano as Senior Vice President and Chief Technology Officer, and Scott Etlinger to the position of Senior Vice President, Global Operations. Mr.

ALBANY, N.Y., Sep 09, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that management will present at upcoming investor conferences during the month

ALBANY, N.Y., Sep 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today reported preliminary unaudited results for its fiscal 2011 first quarter ended August

<i><b>New Access System Cuts Number of Procedure Steps in Half for
Varicose Vein Treatment</b></i>

ALBANY, N.Y., Aug 03, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 30 th Annual Canaccord Genuity Growth Conference in

<ul>
<li class="bwlistitemmarginbottom">
<i><b>Fourth Quarter Net Sales Increase 14% to $60.3 Million</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>First $1.0 Million NanoKnife(R) IRE System Net Sales Quarter</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Record $16.1 Million Operating Cash Flow Quarter</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Fourth Quarter Net Income Grows 29%</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Company Provides Guidance for FY 2011</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Conference Call Begins Today at 4:30 p.m. Eastern Time</b></i>
</li>
</ul>